Effect of short-acting B1-blocker on perioperative arrhythmia including atrial fibrillation after resection of anterior mediastinal tumors

Effect of short-acting B1-blocker on perioperative arrhythmia including atrial fibrillation after resection of anterior mediastinal tumors - Effect of short-acting B1-blocker on perioperative arrhythmia including atrial fibrillation after resection of anterior mediastinal tumors

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011912

Enrollment

100

Registered

2013-10-07

Start date

2013-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative arrhythmia including atrial fibrillation after resection of anterior mediastinal tumors

Interventions

Effect of short-acting B1-blocker

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients treated with landiolol hydrochloride for the treatment of tachyarrhythmia in the perioperative resection of anterior mediastinal tumors

Exclusion criteria

Exclusion criteria: 1. Patients corresponding to the contraindication of landiolol hydrochloride 2.Patients aged under 20 3.Patients who or whose legal representative has no ability of informed consent 4.Judged as being unsuitable for the trial by the researcher.

Design outcomes

Primary

Measure	Time frame
Tachyarrhythmia occurrence frequency (Changes in heart rate)	—

Secondary

Measure	Time frame
1. Measurement of Inflammation response (WBC, CRP) 2. Length of stay in intensive care unit after surgery 3. Length of stay at hospital	—

Countries

Japan

Contacts

Public ContactRyota Masuda

Tokai University School of Medicine Department of general thoracic Surgery

masudar@is.icc.u-tokai.ac.jp0463-93-1121

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026